Published on 29 Oct 2024 on Benzinga
AbbVie Inc ABBV will be reporting its third-quarter earnings on Wednesday. Wall Street expects $2.92 in EPS and $14.28 billion in revenues as the company reports before market hours.
Ahead of its third-quarter earnings report, AbbVie bolstered its Alzheimer's research efforts with the $1.4 billion acquisition of Aliada Therapeutics, announced on Monday.